Effect of Cryotherapy in the Prevention of Madarosis Produced by Chemotherapy in Breast Cancer Patients
Recruiting
N/A
Interventional Study
Breast Neoplasms
Alopecia
Madarosis
Eyebrow Diseases
Eyelash Diseases
Anthracyclines
Taxoids
Side Effects
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 120 (estimated)
- Sponsor
- University of Salamanca · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Chemotherapy-induced alopecia (CIA) significantly compromises body image in breast cancer patients, particularly when involving eyebrow and eyelash loss (madarosis). While scalp cooling devices are routinely employed to prevent scalp alopecia, no standardized interventions exist for madarosis prevention. This quasi-experimental study assesses the efficacy of targeted eyebrow cryotherapy in reducin…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female participants aged ≥18 years
* Newly diagnosed breast cancer (any stage)
* Scheduled to receive anthracycline- and/or taxane-based chemotherapy as first-line systemic treatment
* No prior history of antineoplastic treatment
* Willing and able to provide written informed …
Contacts